Underlying mechanism is increased inflammation, activation of oncogenic transcription factor

-- Rick Ansorge

Monday, January 25, 2010 (Last Updated: 01/26/2010)

MONDAY, Jan. 25 (HealthDay News) -- Obesity promotes hepatocellular carcinoma by stimulating production of two inflammatory cytokines, according to an animal study in the Jan. 22 issue of Cell.

Eek Joong Park, of the University of California-San Diego School of Medicine in La Jolla, and colleagues studied the effects of obesity on the development of chemically-induced hepatocellular carcinoma in laboratory mice.

The researchers found that obesity stimulates production of interleukin-6 and tumor necrosis factor, resulting in chronic, low-grade inflammation and activation of the oncogenic transcription factor STAT3. The research suggests that anti-tumor necrosis factor drugs may prevent hepatocellular carcinoma development in obese men with chronic liver disease.

"The chronic inflammatory response caused by obesity and enhanced production of interleukin-6 and tumor necrosis factor may also increase the risk of other cancers," the authors write.

Abstract
Full Text

Specialties Radiology
Oncology
OBGYN & Women's Health

Copyright © 2010 HealthDay. All rights reserved.

Blogs

Vegetarian Snacks: Baked Apple
by OncoLink Editorial Team
February 28, 2013

Breaking news: Supreme Court votes to uphold Affordable Care Act Subsidies
by Christina Bach, MSW, LCSW, OSW-C
June 26, 2015